{"id":"W2059451555","doi":"10.1007/s10875-011-9588-5","title":"Efficacy and Safety of Subcutaneous Vivaglobin® Replacement Therapy in Previously Untreated Patients with Primary Immunodeficiency: A Prospective, Multicenter Study","year":2011,"lang":"en","type":"article","venue":"Journal of Clinical Immunology","topic":"Immunodeficiency and Autoimmune Disorders","field":"Immunology and Microbiology","cited_by":51,"is_retracted":false,"has_abstract":false,"ca_institutions":"McGill University; Montreal Children's Hospital; University of Alberta","funders":"CSL Behring","keywords":"Medicine; Primary immunodeficiency; Regimen; Adverse effect; Clinical endpoint; Prospective cohort study; Quality of life (healthcare); Multicenter study; Internal medicine; Surgery; Pediatrics; Clinical trial; Randomized controlled trial; Disease","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001349371,0.0006697949,0.001495194,0.0003270314,0.0003582694,0.0007698745,0.000459873,0.0008560491,0.0008369712],"category_scores_gemma":[0.001774263,0.0003213875,0.0008039078,0.0005580575,0.0009637378,0.0006727435,0.0002192432,0.0008961875,0.0002364923],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003657542,"about_ca_system_score_gemma":0.0003786706,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004446954,"about_ca_topic_score_gemma":0.0002805416,"domain_scores_codex":[0.9992059,0.0004084375,0.00005789835,0.0001351675,0.0001084468,0.00008420674],"domain_scores_gemma":[0.9982424,0.0006380156,0.0005264424,0.0001815922,0.00007475726,0.0003368524],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.3212011,0.01467456,0.5891014,0.0003006682,0.002188208,0.0009798174,0.0005827514,0.001035966,0.0242881,0.0001898781,0.0003623306,0.04509537],"study_design_scores_gemma":[0.03788819,0.2596051,0.6936871,0.0000418602,0.001490205,0.001720825,0.0003069307,0.001777327,0.002338419,0.0001359527,0.0009466682,0.00006141876],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9990447,0.0006893539,0.00005538086,0.00001551176,0.000005235263,0.0000180621,0.00003513045,0.000002603052,0.0001339327],"genre_scores_gemma":[0.9994056,0.0002323949,0.0000626453,0.00004104604,0.00003394169,0.00001706835,0.0001249618,0.000001572383,0.00008066692],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001495194,"threshold_uncertainty_score":0.007136285,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01930028240455464,"score_gpt":0.2788561340375268,"score_spread":0.2595558516329722,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}